Sigyn Therapeutics Appoints Ajay Verma, M.D., Ph.D. to its Scientific Advisory Board
31. März 2022 08:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, March 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (OTC Markets:“SIGY”), a medical technology company focused on the treatment of pathogen-associated...
Sigyn Therapeutics (SIGY) CEO Note: Rethinking the Treatment of Sepsis and Other Life-Threatening Inflammatory Conditions
02. November 2020 07:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Nov. 02, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (OTCMarkets: SIGY), today released the following note authored by its Chairman and CEO, Jim Joyce. ...
PreveCeutical Announces Incorporation of Australian Subsidiary to Support Ongoing Research Programs
16. März 2018 09:00 ET
|
PreveCeutical Medical Inc.
VANCOUVER, British Columbia, March 16, 2018 (GLOBE NEWSWIRE) -- via NetworkWire – PreveCeutical Medical Inc. (the “Company” or “PreveCeutical”) (CSE:PREV) (OTCQB:PRVCF) (FSE:18H), announces the...